SEC Company Response from Advanced Life Sciences Holdings, Inc. (CIK 0001322734) — Jul 25, 2005
Advanced Life Sciences Holdings, Inc. (CIK 0001322734)
Date: July 25, 2005 · CIK: 0001322734 · Accession: 0001047469-05-019996
AI Filing Summary & Sentiment
File numbers found in text: 333-124396
Letter
Division of Corporate Finance Securities and Exchange Commission Washington, D.C. 20549 Re:Advanced Life Sciences Holdings, Inc. ("ALS") Registration Statement on Form S-1 File No. 333-124396
Dear Mr. Riedler:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, ALS hereby respectfully requests that the Securities and Exchange Commission take such action as may be necessary and proper in order that the above-referenced Registration Statement be declared effective at 3:30 p.m. (Washington D.C. time), on Wednesday, July 27, 2005, or as soon thereafter as practicable.
Please call Cab Morris (312) 558-5609 to provide notice of the effectiveness of the Registration Statement.
Respectfully submitted,
/s/ MICHAEL T. FLAVIN Michael T. Flavin
Chairman and Chief Executive Officer
Advanced Life Sciences Holdings, Inc.
C.E. Unterberg, Towbin
350 Madison Avenue
New York, New York 10017
July 25,
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, NE
Washington, D.C. 20549
Re:Advanced Life Sciences Holdings, Inc.
Registration Statement on Form S-1
File No. 333-124396
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), we hereby join Advanced Life Sciences Holdings, Inc. (the "Company") in requesting that the Registration Statement referred to above be declared effective at 3:30 p.m. Eastern Time on July 27, 2005 or as soon thereafter as practicable.
In connection with this acceleration request and pursuant to Rule 460 under the Act, the following information is provided with respect to the distribution through the date of this letter of the Preliminary Prospectus dated July 1, 2005.
To Whom Distributed
Number of Copies
Underwriters
Dealers
Institutions
1,400
Individuals
Total
1,467
This is to further advise you that the underwriters have complied and will continue to comply with Rule 15c2-8 under the Securities and Exchange Act of 1934, as amended, in connection with the above-described issue.
Sincerely,
C.E. UNTERBERG, TOWBIN, LLC
Show Raw Text
CORRESP
1
filename1.htm
Advanced Life Sciences Holdings, Inc.
1440 Davey Road
Woodridge, Illinois 60517
July 25, 2005
Jeffrey P.
Riedler
Assistant Director
Division of Corporate Finance
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Re:Advanced Life Sciences Holdings, Inc. ("ALS")
Registration Statement on Form S-1
File No. 333-124396
Dear Mr. Riedler:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, ALS hereby respectfully requests that the Securities and Exchange Commission take such action as may be
necessary and proper in order that the above-referenced Registration Statement be declared effective at 3:30 p.m. (Washington D.C. time), on Wednesday, July 27, 2005, or as soon
thereafter as practicable.
Please
call Cab Morris (312) 558-5609 to provide notice of the effectiveness of the Registration Statement.
Respectfully submitted,
/s/ MICHAEL T. FLAVIN Michael T. Flavin
Chairman and Chief Executive Officer
Advanced Life Sciences Holdings, Inc.
C.E. Unterberg, Towbin
350 Madison Avenue
New York, New York 10017
July 25,
2005
Securities
and Exchange Commission
Division of Corporation Finance
100 F. Street, NE
Washington, D.C. 20549
Re:Advanced Life Sciences Holdings, Inc.
Registration Statement on Form S-1
File No. 333-124396
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the "Act"), we hereby join Advanced Life Sciences Holdings, Inc. (the "Company") in requesting that the
Registration Statement referred to above be declared effective at 3:30 p.m. Eastern Time on July 27, 2005 or as soon thereafter as practicable.
In
connection with this acceleration request and pursuant to Rule 460 under the Act, the following information is provided with respect to the distribution through the date of
this letter of the Preliminary Prospectus dated July 1, 2005.
To Whom Distributed
Number of Copies
Underwriters
2
Dealers
15
Institutions
1,400
Individuals
50
Total
1,467
This
is to further advise you that the underwriters have complied and will continue to comply with Rule 15c2-8 under the Securities and Exchange Act of 1934, as amended, in
connection with the above-described issue.
Sincerely,
C.E. UNTERBERG, TOWBIN, LLC
THINKEQUITY LLC
MERRIMAN CURHAN FORD & Co.
As Representatives
By:
C.E. Unterberg, Towbin, LLC
/s/ ANDY ARNO Andy Arno
Chairman